Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Neurol Neurosci Rep. 2009 Sep;9(5):384-9.

Current pharmacologic testing for Horner syndrome.

Author information

  • 1The University of Iowa Hospitals and Clinics, Department of Ophthalmology and Visual Sciences, IA 52242, USA.

Abstract

First described in 1727, Horner syndrome occurs from injury to one of the three neurons in the oculosympathetic pathway. Its presence can be confirmed with pharmacologic testing, traditionally including cocaine testing with hydroxyamphetamine localization. More recently, apraclonidine testing has become a viable alternative in some practices. Concern has been raised regarding the possibility of false-negative results with apraclonidine testing as well as the safety of its use in young children.

PMID:
19664368
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk